3FD-31477-74054
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 750 / TX
- Registered
- 2021-06-17
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-17
Registered in v-safe
-
2021-06-17
Dose 1 — Pfizer-BioNTech
- 2021-06-17
- 2021-06-18
- 2021-06-19
- 2021-06-20
- 2021-06-23
- 2021-06-24
- 2021-07-01
-
2021-07-08
Dose 2 — Pfizer-BioNTech
- 2021-07-08
-
2021-07-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-07-11
- 2021-07-14
- 2021-07-15
- 2021-07-29
-
2022-01-08
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid positiveMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-17 | Pfizer-BioNTech | |
| 2 | 2021-07-08 | Pfizer-BioNTech | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Covid positive
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release